The extent and impact of pharmaceutical opioids for chronic non-cancer pain

阿片类药物治疗慢性非癌性疼痛的程度和影响

• 批准号: nhmrc : GNT1119992
• 负责人: Dr Gabrielle Campbell
• 金额: $ 31.88万
• 依托单位国家: 澳大利亚
• 项目类别: Early Career Fellowships
• 财政年份: 2017
• 资助国家: 澳大利亚
• 起止时间: 2017-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/extent-impact-pharmaceutical-cancer-pain/1347093
• 关键词: extent; impact; pharmaceutical; opioids; chronic

There have been dramatic increases in the use of pharmaceutical opioids (PO) for chronic non-cancer pain (CNCP), despite limited data on their long-term effectiveness and an increase in associated harm. This Fellowship provides critical new data to inform both clinicians and policymakers on the global extent of PO for CNCP, trajectories of problematic use and associated morbidity and a unique evaluation of the impact of real-time prescription monitoring program to reduce these harms.

药物阿片类药物（PO）用于慢性非癌症疼痛（CNCP）的使用急剧增加，尽管有关其长期有效性的数据有限，并且相关危害增加。该奖学金提供了重要的新数据，以告知临床医生和政策制定者关于CNCP PO的全球范围，有问题的使用和相关发病率的轨迹以及对实时处方监测计划的影响的独特评估，以减少这些伤害。